Haemonetics Corporation · NYSE:HAE
DArecca James received 29,312 Haemonetics Corporation shares as an award (Form 4)
Traded May 15, 2026 · Filed May 19, 2026
On May 15, 2026, DArecca James (EVP, Chief Financial Officer) received 29,312 Haemonetics Corporation shares as an award, leaving 54,444 shares. Filed May 19, 2026 (Form 4).
- Awarded
- 29,312 shares
- Holding after
- 54,444 shares
- Trading plan
- No
- Role
- EVP, Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 15, 2026 | Common Stock | Shares withheld for tax | 2,505 | US$56.29 | 25,132 | Direct |
| May 15, 2026 | Common Stock | Award | 29,312 | 54,444 | Direct |
Source
Related
- Haemonetics Corporation
- DArecca James
- Haemonetics Corporation shareholders
- Form 4 · DArecca James · May 5, 2026
- Schedule 13G/A · AQR Capital Management LLC · Aug 12, 2026
- Form 4 · Abernathy Robert E · Jul 28, 2026
- Form 4 · Madaus Martin D · Jul 28, 2026
- Form 4 · Zane Ellen M · Jul 28, 2026
- Form 4 · Pomeroy Claire · Jul 28, 2026